New cannabis products highly potent, pose mental health risks

February 12, 2018, American Osteopathic Association

Schizophrenia and other psychiatric issues may be triggered by marijuana use, according to a research analysis in the Journal of the American Osteopathic Association.

With states rapidly legalizing for medicinal and recreational use, physicians will be increasingly pressed to counsel patients on their frequency of use and dosage, as well as associated risks. The special report in the JAOA aggregates what is known to help physicians give the best evidence-based recommendations.

"We have a special concern for young people in their late teens and early twenties, whose brains are still developing," says Jeramy Peters, DO, lead study author and psychiatrist at Oregon Health and Science University in Portland.

Dr. Peters adds that while there is no simple way to predict which might develop issues as a result of marijuana use, a family history of mental illness could suggest potential risk.

"Pediatricians should be aware of this, especially for patients who have exhibited symptoms of anxiety and depression, and be willing to have candid discussions about cannabis," says Dr. Peters.

Some longer-term effects associated with cannabis use include impaired memory and concentration, and decreased motivation. Researchers say when cannabis use starts to impair an individual's health status or social or occupational functioning, he or she should be counseled to stop using cannabis or referred to substance abuse treatment providers.

Patients without mental health or substance abuse problems, who use cannabis recreationally or medicinally, can still benefit from physician counsel.

Know your cannabinoid

The main pharmacologically active chemicals in cannabis are the cannabinoids Tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is responsible for the "high" people experience and there is moderate-quality evidence that THC may help chronic neuropathic or cancer pain. However, it has also been shown to induce symptoms of psychosis among healthy study volunteers and is thought to be a risk factor in developing psychosis.

Conversely, CBD is theorized to have antipsychotic and anxiolytic properties. Currently, CBD is being studied for its possible antiseizure and anti-inflammatory properties.

Many new products contain varied ratios of THC and CBD in order to create specific euphoric and medicinal effects. Researchers recommend physicians be aware of what products their patients are using—as well as how much and how often—in order to best advise them on dosing and risks.

"It is very difficult to tell someone what effect they can expect without knowing the specifics of the product," says Walter Prozialeck, Ph.D., professor and chair of the Department of Pharmacology, Chicago College of Osteopathic Medicine at Midwestern University. "How much THC is in the product, how it's consumed—and, of course, the individual's physiology—all play a role in determining their experience."

Dosing not always straightforward

The strength of cannabis has been increasing over the past half century. During the 1960s, cannabis was typically about 1% to 5% THC by weight. Many strains available today range from 15% to 25% THC by weight, with some strains reaching 30% or higher. When smoked, about 25% of the cannabinoids present in get absorbed.

However, when inhaling cannabis via a vaporizer, the user absorbs up to 33% of the total cannabinoids. People who smoke or vape also experience the effects quickly, with intoxication setting in within 2 minutes and lasting 2-4 hours. The near immediate onset of the high allows users to titrate their dosing more effectively.

By comparison, when cannabis products are ingested orally, THC is absorbed inconsistently. Users typically experience the effects of THC about 2 to 4 hours after ingestion, and its effects last for 6 to 8 hours. Persons who ingest cannabis products often experience a more intense and longer-lasting effect. Given the significant delay of intoxication, it is much easier to overdose and experience negative effects.

"The best advice we can give is start low and go slow," says Prozialeck. He adds that more research is needed from the medical community to create specific protocols that physicians can use to better counsel patients.

Explore further: An ingredient in cannabis may be useful for treating psychosis – new study

More information: Jeramy Peters et al, Contemporary Routes of Cannabis Consumption: A Primer for Clinicians, The Journal of the American Osteopathic Association (2018). DOI: 10.7556/jaoa.2018.020

Related Stories

An ingredient in cannabis may be useful for treating psychosis – new study

December 15, 2017
Psychiatric patients treated with a substance found in cannabis, cannabidiol, showed a significant reduction in psychotic symptoms and were also more likely to be rated as "improved" by their psychiatrist, our latest study ...

Component of marijuana may help treat anxiety and substance abuse disorders

March 8, 2017
Cannabidiol, a major component of cannabis or marijuana, appears to have effects on emotion and emotional memory, which could be helpful for treating anxiety-related and substance abuse disorders.

Canada should continue with separate medical stream after cannabis is legalized for recreational use

July 17, 2017
After cannabis is legalized, Canada should continue with a separate medical cannabis stream to keep patients safe, argues a commentary in CMAJ (Canadian Medical Association Journal)

Questions remain about the benefits and harms of cannabis

April 3, 2017
Despite dramatic changes in the legal landscape and usage rates of cannabis, evidence is still lacking regarding its potential health and therapeutic effects. Recently, the National Academies of Sciences, Engineering, and ...

As access to legal marijuana increases, researchers explore patient use

November 27, 2017
About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year, according to a study conducted by Kaiser Permanente researchers since Washington state legalized ...

Marijuana could help treat drug addiction, mental health

November 16, 2016
Using marijuana could help some alcoholics and people addicted to opioids kick their habits, a UBC study has found.

Recommended for you

Parental life span predicts daughters living to 90 without chronic disease or disability

August 15, 2018
Researchers at the University of California San Diego School of Medicine report that women whose mothers lived to at least age 90 were more likely to also live to 90, free of serious diseases and disabilities.

Widespread declines in life expectancy across high income countries coincide with rising young adult, midlife mortality

August 15, 2018
The ongoing opioid epidemic in the United States is a key contributor to the most recent declines in life expectancy, suggests a study published by The BMJ today.

Diets high in vegetables and fish may lower risk of multiple sclerosis

August 15, 2018
People who consume a diet high in vegetables and fish may have a reduced risk of multiple sclerosis, new research led by Curtin University has found.

Can sleeping too much lead to an early death?

August 15, 2018
A recent study in the Journal of the American Heart Association has led to headlines that will make you rethink your Saturday morning sleep in.

Mixing energy drinks with alcohol could enhance the negative effects of binge drinking

August 14, 2018
A key ingredient of energy drinks could be exacerbating some of the negative effects of binge drinking according to a new study.

New study finds fake, low-quality medicines prevalent in the developing world

August 10, 2018
A new study from the University of North Carolina at Chapel Hill found that substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world. In low- and middle-income ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.